Download PDF
Thromb Haemost 2004; 92(01): 132-139
DOI: 10.1160/TH03-08-0535
Platelets and Blood Cells
Schattauer GmbH

Tissue factor messenger RNA levels in leukocytes compared with tissue factor antigens in plasma from patients in hypercoagulable state caused by various diseases

Tomohiro Sase
1   Second Department of Internal Medicine, Mie University School of Medicine, Tsu, Japan
,
Hideo Wada
2   Department of Laboratory Medicine, Mie University School of Medicine, Tsu, Japan
,
Yuko Kamikura
1   Second Department of Internal Medicine, Mie University School of Medicine, Tsu, Japan
,
Toshihiro Kaneko
3   Department of Safety Management, Mie University School of Medicine, Tsu, Japan
,
Yasunori Abe
4   Clinical Laboratories, Mie University Hospital, Tsu, Japan
,
Junji Nishioka
4   Clinical Laboratories, Mie University Hospital, Tsu, Japan
,
Tsutomu Nobori
2   Department of Laboratory Medicine, Mie University School of Medicine, Tsu, Japan
,
Hiroshi Shiku
1   Second Department of Internal Medicine, Mie University School of Medicine, Tsu, Japan
› Author Affiliations
Further Information

Publication History

Received 22 August 2003

Accepted after resubmission 25 April 2004

Publication Date:
29 November 2017 (online)

    Permissions and Reprints

Summary

We compared the levels of tissue factor (TF) mRNA in leukocytes with plasma TF antigens of patients in hypercoagulable state caused by various diseases. Flow cytometric analysis showed absence of TF antigen expression on neutrophils and monocytes in healthy subjects but strong expression in both cell types of patients with infections. TF mRNA levels in leukocytes were low in healthy subjects but they were significantly elevated in patients with underlying diseases of disseminated intravascular coagulation (DIC), especially in acute myeloid leukaemia (AML) and infections. TF mRNA levels in leukocytes were significantly high in patients with all diseases except those with thrombosis, and plasma TF antigen levels were significantly high in all diseases. TF mRNA in leukocytes and plasma TF antigen levels were significantly high in patients with overt-DIC, and TF mRNA/antigen ratio was significantly high in patients with overt-DIC. In patients with solid cancers, TF mRNA and TF mRNA/antigen ratio were significantly higher in patients with metastases than those without. TF mRNA levels in leukocytes and plasma levels of TF antigen did not correlate in normal subjects and all patients, but they tended to be correlated in patients with AML, infections or overt-DIC. Our analysis suggests that TF expression in leukocytes plays an important role in various diseases but the expression level does not always correlate with plasma levels of TF antigen.

Keywords

Tissue factor - disseminated intravascular coagulation - infection - cancer - hypercoagulability
 

  • References

  • 1 Camerer E, Kolsto AB, Prydz H. Cell biology of tissue factor, the principal initiator of blood coagulation. Thromb Res 1996; 81: 1-41.
    CrossrefPubMedGoogle Scholar
  • 2 Taylor Jr. FB, Chang A, Ruf W. et al. Lethal E. coli septic shock is prevented by blocking tissue factor with monoclonal antibody. Circ Shock 1991; 33: 127-34.
    PubMedGoogle Scholar
  • 3 De Jonge E, Dekkers PE, Creasey AA. et al. Tissue factor pathway inhibitor dose-dependently inhibits coagulation activation without influencing the fibrinolytic and cytokine response during human endotoxemia. J Infect Dis 2001; 183: 1815-8.
    CrossrefPubMedGoogle Scholar
  • 4 Jilma B, Marsik C, Mayr F. et al. Pharmacodynamics of active site-inhibited factor VIIa in endotoxin-induced coagulation in humans. Clin Pharmacol Ther 2002; 72: 403-10.
    CrossrefPubMedGoogle Scholar
  • 5 Contrino J, Hair G, Kreutzer DL. et al. In situ detection of tissue factor in vascular endothelial cells: correlation with the malignant phenotype of human breast disease. Nat Med 1996; 02: 209-15.
    CrossrefPubMedGoogle Scholar
  • 6 Muller M, Albrecht S, Golfert F. et al. Localization of tissue factor in actin-filamentrich membrane areas of epithelial cells. Exp Cell Res 1999; 248: 136-47.
    CrossrefPubMedGoogle Scholar
  • 7 Masuda M, Nakamura S, Murakami T. et al. Association of tissue factor with a γ-chain homodimer of IgE receptor type I in cultured human monocytes. Eur J Immunol 1996; 26: 2529-32.
    CrossrefPubMedGoogle Scholar
  • 8 Grignani G, Maiolo A. Cytokines and hemostasis. Haematologica 2000; 85: 967-72.
    PubMedGoogle Scholar
  • 9 Franco RF, de Jonge E, Dekkers PE. et al. The in vivo kinetics of tissue factor messenger RNA expression during human endotoxemia: relationship with activation of coagulation. Blood 2000; 96: 554-9.
    PubMedGoogle Scholar
  • 10 Crossman DC, Carr DP, Tuddenham EGD. et al. The regulation of tissue factor mRNA in human endothelial cells in response to endotoxin or phorbol ester. J Biol Chem 1990; 265: 9782-7.
    PubMedGoogle Scholar
  • 11 Bevilacqua MP, Pober JS, Majeau GR. et al. Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: Characterization and comparison with the actions of interleukin 1. Proc Natl Acad Sci USA 1986; 83: 4533-7.
    CrossrefPubMedGoogle Scholar
  • 12 Koyama T, Nishida K, Ohdama S. et al. Determination of plasma tissue factor antigen and its clinical significance. Br J Haematol 1994; 87: 343-7.
    CrossrefPubMedGoogle Scholar
  • 13 Wada H, Nakase T, Nakaya R. et al. Elevated plasma tissue factor antigen level in patients with disseminated intravascular coagulation. Am J Hematol 1994; 45: 232-6.
    CrossrefPubMedGoogle Scholar
  • 14 Kakkar AK, DeRuvo N, Chinswangwatanakul V. et al. Extrinsic-pathway activation in cancer with high factor VIIa and tissue factor. The Lancet 1995; 346: 1004-5.
    CrossrefPubMedGoogle Scholar
  • 15 Sase T, Wada H, Nishioka J. et al. Measurement of tissue factor messenger RNA levels in leukocytes from patients in hypercoagulable state caused by several underlying diseases. Thromb Haemost 2003; 89: 660-5.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 16 Taylor Jr. F, Toh CH, Hoots K. et al. Towards definition clinical and laboratory criteria and a scoring system for disseminated intravascular coagulation. On behalf of the Scientific Subcommittee on disseminated intravascular coagulation (DIC) of the International Society on Thrombosis and Haemostasis (ISTH). Thromb Haemost 2001; 86: 1327-30.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 17 Holmes VA, Wallace JMW, Gilmore WS. et al. Tissue factor expression on monocyte subpopulations during normal pregnancy. Thromb Haemost 2002; 87: 953-8.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 18 Mensink E, van de Locht, Schattenberg A. et al. Quantitation of minimal residual disease in Philadelphia chromosome positive chronic myeloid leukemia patients using realtime quantitative RT-PCR. Br J Hematol 1998; 102: 768-74.
    CrossrefPubMedGoogle Scholar
  • 19 Todoroki H, Nakamura S, Higure A. et al. Neutrophils express tissue factor in a monkey model of sepsis. Surgery 2000; 127: 209-16.
    CrossrefPubMedGoogle Scholar
  • 20 Imamura T, Kaneda H, Nakamura S. New functions of neutrophils in the arthus reaction: Expression of tissue factor, the clotting initiator, and fibrinolysis by elastase. Lab Invest 2002; 82: 1287-95.
    CrossrefPubMedGoogle Scholar
  • 21 Giesen PL, Rauch U, Bohrmann B. et al. Bloodborn tissue factor: Another view of thrombosis. Proc Natl Acad Sci USA 1999; 96: 2311-5.
    CrossrefPubMedGoogle Scholar
  • 22 Wada H, Nagano T, Tomeoku M. et al. Coagulant and fibrinolytic activities in the leukemic cell lysates. Thromb Res 1982; 30: 315-22.
    PubMedGoogle Scholar
  • 23 Amirkhosravi A, Alexander M, May K. et al. The importance of platelets in the expression of monocyte tissue factor antigen measured by new whole blood flow cytometric assay. Thromb Haemost 1996; 75: 87-95.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 24 Song SJ, Wang LL, Wei WN. Tissue factor expression in human umbilical vein endothelial cells stimulated by TNF-alpha and its molecular mechanism. Zhogguo Shi Yan Xue Ye Xue Za Zhi 2003; 11: 124-7.
    PubMedGoogle Scholar
  • 25 Wada H, Ohiwa M, Kaneko T. et al. Plasma level of tumor necrosis factor in disseminated intravascular coagulation. Am J Hematol 1991; 37: 147-51.
    CrossrefPubMedGoogle Scholar
  • 26 Wada H, Tamaki S, Tanigawa M. et al. Plasma level of IL-1β in disseminated intravascular coagulation. Thromb Haemost 1991; 65: 364-8.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 27 Wada H, Tanigawa M, Wakita Y. et al. Increased plasma level of interleukin-6 in disseminated intravascular coagulation. Blood Coagul Fibrinolysis 1993; 04: 583-90.
    CrossrefPubMedGoogle Scholar
  • 28 Salgado A, Boveda J, Monaterio J. et al. Inflammatory mediators and their influence on hemostasis. Haemostasis 1994; 24: 132-8.
    PubMedGoogle Scholar
  • 29 Gregory SA, Morrissey JH, Edgington TS. Regulation of tissue factor gene expression in the monocyte procoagulant response to endotoxin. Mol Cell Biol 1989; 09: 2752-5.
    CrossrefPubMedGoogle Scholar
  • 30 Wen ZB, Xiong SL, He XF. et al. Observation on tissue factor pathway and other coagulation parameter during the onset of acute cerebrocardiac thrombotic diseases. Thromb Res 2002; 107: 223-8.
    CrossrefPubMedGoogle Scholar
  • 31 Asakura H, Kamikubo Y, Goto A. et al. Role of tissue factor in disseminated intravascular coagulation. Thromb Res 1995; 80: 217-24.
    CrossrefPubMedGoogle Scholar
  • 32 Nakamura S. Tissue factor: Its new aspect and highly sensitive ELISA for clinical use. Hematol Oncol 1995; 31: 66-74.
    PubMedGoogle Scholar
  • 33 Bogdanov VY, Balasubramanian V, Hathcock J. et al. Alternatively spliced human tissue factor: a circulating, soluble, thrombogenic protein. Nat Med 2003; 04: 458-62.
    PubMedGoogle Scholar
  • 34 Giesen PL, Nemerson Y. Tissue factor on the loose. Semin Thromb Hemost 2000; 26: 379-84.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 35 Dasmahapatra KS, Cheung NK, Spillert C. et al. An assessment of monocyte procoagulant activity in patients with solid tumors. J Surg Res 1987; 43: 158-63.
    CrossrefPubMedGoogle Scholar
  • 36 Osterud B, Due Jr J. Blood coagulation in patients with benign and malignant tumors before and after surgery. Special reference to thromboplastin generation in monocytes. Scand J Haematol 1984; 32: 258-64.
    PubMedGoogle Scholar
  • 37 Nakasaki T, Wada H, Shigemori C. et al. Expression of tissue factor and vascular endothelial growth factor is associated with angiogenesis in colorectal cancer. Am J Hematol 2002; 69: 247-54.
    CrossrefPubMedGoogle Scholar
  • 38 Shigemori C, Wada H, Matsumoto K. et al. Tissue factor expression and metastatic potential of colorectal cancer. Thrombo Haemost 1998; 80: 894-8.
    PubMedGoogle Scholar
  • 39 Mueller BM, Reisfeld RA, Edginton TS. et al. Expression of tissue factor by melanoma cells promotes efficient hematogenous metastasis. Proc Natl Acad Sci USA 1992; 89: 11832-6.
    CrossrefPubMedGoogle Scholar